Injecting sensory nerves within head and neck tumors with extracellular vesicles from p53 (also known as TP53)-deficient cancer cells in vivo reprogrammed these nerves into norepinephrine-producing adrenergic nerves (Amit et al., 2020). Here, TP53 is linked to cancer.